QIAGEN Reports Results for First Quarter 2017

Go back to QIAGEN Reports Results for First Quarter 2017

Qiagen NV (QGEN) PT Raised to $31.50 at Evercore ISI

May 3, 2017 11:01 AM EDT

Evercore ISI raised its price target on Qiagen NV (NASDAQ: QGEN) to $31.50 (from $30.00) while maintaining a Outperform rating following results, saying the turnaround remains on track.

Analyst Vijay Kumar noted constant currency revenue beat driven by slightly better M&A contribution and generally... More

Qiagen (QGEN) Misses Q1 EPS by 1c; Reaffirms

May 2, 2017 4:06 PM EDT

Qiagen (NASDAQ: QGEN) reported Q1 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $306.89 million.

QIAGEN reaffirms full-year 2017 outlook for 6-7% CER sales growth and adjusted EPS target before restructuring... More